Evidence map›Paper›PMID 31711903›Full record

ArticleReproductive toxicology (Elmsford, N.Y.)2020

Exposure-based assessment of chemical teratogenicity using morphogenetic aggregates of human embryonic stem cells.

Yusuke Marikawa, Hong-Ru Chen, Mark Menor, Youping Deng, Vernadeth B Alarcon

Open access · greenAbstract read
In one paragraph

Article in Reproductive toxicology (Elmsford, N.Y.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Detection of developmental toxicity of the anti-COVID-19 drug molnupiravir using gastruloid-based in vitro assays.Toxicological sciences : an official journal of the Society of Toxicology · 2025
    Article
  7. Article
  8. Three-dimensional stem cell models of mammalian gastrulation.BioEssays : news and reviews in molecular, cellular and developmental biology · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Yusuke MarikawaInstitute for Biogenesis Research, Department of Anatomy, Biochemistry and Physiology, University of Hawaii John A. Burns School of Medicine, Honolulu, HI, USA. Electronic address: marikawa@hawaii.edu.
Hong-Ru ChenDepartment of Obstetrics and Gynecology, University of Hawaii John A. Burns School of Medicine, Honolulu, HI, USA.
Mark MenorDepartment of Complementary and Integrative Medicine, University of Hawaii John A. Burns School of Medicine, Honolulu, HI, USA.
Youping DengDepartment of Complementary and Integrative Medicine, University of Hawaii John A. Burns School of Medicine, Honolulu, HI, USA.
Vernadeth B AlarconInstitute for Biogenesis Research, Department of Anatomy, Biochemistry and Physiology, University of Hawaii John A. Burns School of Medicine, Honolulu, HI, USA.
University of Hawaiʻi at Mānoa · US

Funding

UH Hilo COP A&RP20GM103466 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI HELEN C TURNER · 2012 to 2026
$60.3M
The Role of gp120 on Cardiovascular Disease in People Living with HIVU54MD007601 · NIMHD · UNIVERSITY OF HAWAII AT MANOA · PI Gehan Devendra · 2017 to 2026
$59.5M
Small Grants ProgramP30GM114737 · NIGMS · UNIVERSITY OF HAWAII AT MANOA · PI YANAGIHARA, RICHARD · 2015 to 2022
$8.1M
Profiling genome-wide circulating ncRNAs for the early detection of lung cancerR01CA223490 · NCI · UNIVERSITY OF HAWAII AT MANOA · PI DENG, YOUPING · 2018 to 2022
$3.1M
EARLY DETECTION OF LUNG CANCER USING METABOLOMIC LIPID PROFILINGR21CA164764 · NCI · RUSH UNIVERSITY MEDICAL CENTER · PI DENG, YOUPING · 2013 to 2014
$360k
Use of stem cell-based morphogenesis models as teratogen screening toolsR03HD088970 · NICHD · UNIVERSITY OF HAWAII AT MANOA · PI MARIKAWA, YUSUKE · 2018 to 2019
$154k
NCI NIH HHS R01 CA223490NCI NIH HHS R21 CA164764NICHD NIH HHS R03 HD088970NIGMS NIH HHS P20 GM103466NIGMS NIH HHS P30 GM114737NIMHD NIH HHS U54 MD007601
6 · The paper itself

Abstract

Pluripotent stem cells recapitulate many aspects of embryogenesis in vitro. Here, we established a novel culture system to differentiate human embryonic stem cell aggregates (HESCA), and evaluated its utility for teratogenicity assessment. Culture of HESCA with modulators of developmental signals induced morphogenetic and molecular changes associated with differentiation of the paraxial mesoderm and neuroectoderm. To examine impact of teratogenic exposures on HESCA differentiation, 18 compounds were tested, for which adequate information on in vivo plasma concentrations is available. HESCA treated with each compound were examined for gross morphology and transcript levels of 15 embryogenesis regulator genes. Significant alterations in the transcript levels were observed for 94% (15/16) of the teratogenic exposures within 5-fold margin, whereas no alteration was observed for 92% (11/12) of the non-teratogenic exposures. Our study demonstrates that transcriptional changes in HESCA serve as predictive indicator of teratogenicity in a manner comparable to in vivo exposure levels.

Indexed as

Cell Culture TechniquesCell AggregationCell DifferentiationCells, CulturedEmbryonic DevelopmentGene Expression Regulation, DevelopmentalHuman Embryonic Stem CellsHumansTeratogenesisTeratogensTeratogens3-dimensional aggregateDaston listEmbryogenesis regulatorsHuman embryonic stem cellInvitro assayNeuroectodermParaxial mesodermTeratogenic exposure

Identifiers

PMID31711903
PMCPMC6980740
OpenAlexW2988031345

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.